# Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) in Ovarian Cancer Recurrence

> **NCT01539785** · NA · UNKNOWN · sponsor: **Catholic University of the Sacred Heart** · enrollment: 158 (estimated)

## Conditions studied

- First Recurrence of Ovarian Cancer

## Interventions

- **PROCEDURE:** Secondary citoreduction
- **PROCEDURE:** Hyperthermic intra-peritoneal chemotherapy (HIPEC)

## Key facts

- **NCT ID:** NCT01539785
- **Lead sponsor:** Catholic University of the Sacred Heart
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2018-09
- **Final completion:** —
- **Target enrollment:** 158 (ESTIMATED)
- **Last updated:** 2014-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01539785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01539785, "Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) in Ovarian Cancer Recurrence". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01539785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*